Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study

Latagliata, R;Capodanno, I;Miggiano, MC;Iurlo, A;Cavazzini, F;Crescenzi, SL;Russo, S;Carmosino, I;Bernardelli, A;Mulas, O;Elena, C;Binotto, G;Crisà, E;Di Veroli, A;Scortechini, AR;Basile, M;Crugnola, M;Murgano, P;Pizzuti, M;Bucelli, C;Fava, C;Dalmazzo, M;Lunghi, F;Caocci, G;Bonifacio, M;Saglio, G;Specchia, G;Breccia, M;Tiribelli, M

2022-01-01